146 related articles for article (PubMed ID: 27423261)
1. Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modeling.
Trifunović J; Borčić V; Vukmirović S; Kon SG; Mikov M
Eur J Pharm Sci; 2016 Sep; 92():194-202. PubMed ID: 27423261
[TBL] [Abstract][Full Text] [Related]
2. Bile acids and their oxo derivatives: Potential inhibitors of carbonic anhydrase I and II, androgen receptor antagonists and CYP3A4 substrates.
Trifunović J; Borčić V; Mikov M
Biomed Chromatogr; 2017 May; 31(5):. PubMed ID: 27743401
[TBL] [Abstract][Full Text] [Related]
3. Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat.
Roda A; Pellicciari R; Gioiello A; Neri F; Camborata C; Passeri D; De Franco F; Spinozzi S; Colliva C; Adorini L; Montagnani M; Aldini R
J Pharmacol Exp Ther; 2014 Jul; 350(1):56-68. PubMed ID: 24784847
[TBL] [Abstract][Full Text] [Related]
4. Reversed- and normal-phase liquid chromatography in quantitative structure retention-property relationships of newly synthesized seco-androstene derivatives.
Milošević NP; Stojanović SZ; Penov-Gaši K; Perišić-Janjić N; Kaliszan R
J Pharm Biomed Anal; 2014 Jan; 88():636-42. PubMed ID: 24216283
[TBL] [Abstract][Full Text] [Related]
5. Bile acids and their oxo derivatives: environmentally safe materials for drug design and delivery.
Trifunović J; Borčić V; Vukmirović S; Vasović V; Mikov M
Drug Chem Toxicol; 2017 Oct; 40(4):397-405. PubMed ID: 27780364
[TBL] [Abstract][Full Text] [Related]
6. Wittig reaction (with ethylidene triphenylphosphorane) of oxo-hydroxy derivatives of 5β-cholanic acid: Hydrophobicity, haemolytic potential and capacity of derived ethylidene derivatives for solubilisation of cholesterol.
Poša M; Bjedov S; Sebenji A; Sakač M
Steroids; 2014 Aug; 86():16-25. PubMed ID: 24819990
[TBL] [Abstract][Full Text] [Related]
7. Chromatographic and computational screening of anisotropic lipophilicity and pharmacokinetics of newly synthesized 1-aryl-3-ethyl-3-methylsuccinimides.
Kovačević S; Banjac MK; Podunavac-Kuzmanović S; Milošević N; Ćurčić J; Vulić J; Šeregelj V; Banjac N; Ušćumlić G
Comput Biol Chem; 2020 Feb; 84():107161. PubMed ID: 31787580
[TBL] [Abstract][Full Text] [Related]
8. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.
Roda A; Minutello A; Angellotti MA; Fini A
J Lipid Res; 1990 Aug; 31(8):1433-43. PubMed ID: 2280184
[TBL] [Abstract][Full Text] [Related]
9. Biliary bile acids in birds of the Cotingidae family: taurine-conjugated (24R,25R)-3α,7α,24-trihydroxy-5β-cholestan-27-oic acid and two epimers (25R and 25S) of 3α,7α-dihydroxy-5β-cholestan-27-oic acid.
Hagey LR; Iida T; Ogawa S; Adachi Y; Une M; Mushiake K; Maekawa M; Shimada M; Mano N; Hofmann AF
Steroids; 2011; 76(10-11):1126-35. PubMed ID: 21600907
[TBL] [Abstract][Full Text] [Related]
10. Determination of critical micellar concentrations of cholic acid and its keto derivatives.
Posa M; Kevresan S; Mikov M; Cirin-Novta V; Sârbu C; Kuhajda K
Colloids Surf B Biointerfaces; 2007 Oct; 59(2):179-83. PubMed ID: 17604970
[TBL] [Abstract][Full Text] [Related]
11. Prediction of In-silico ADME Properties of 1,2-O-Isopropylidene Aldohexose Derivatives.
Kovačević SZ; Jevrić LR; Podunavac Kuzmanović SO; Lončar ES
Iran J Pharm Res; 2014; 13(3):899-907. PubMed ID: 25276190
[TBL] [Abstract][Full Text] [Related]
12. Structure-retention behaviour of biologically active fused 1,2,4-triazinones--correlation with in silico molecular properties.
Sztanke M; Tuzimski T; Janicka M; Sztanke K
Eur J Pharm Sci; 2015 Feb; 68():114-26. PubMed ID: 25528370
[TBL] [Abstract][Full Text] [Related]
13. The influence of NaCl on hydrophobicity of selected, pharmacologically active bile acids expressed with chromatographic retention index and critical micellar concentration.
Posa M; Pilipović A; Lalić M
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):336-43. PubMed ID: 20702073
[TBL] [Abstract][Full Text] [Related]
14. in vitro and in silico determination of oral, jejunum and Caco-2 human absorption of fatty acids and polyphenols. Micellar liquid chromatography.
Stępnik KE; Malinowska I; Rój E
Talanta; 2014 Dec; 130():265-73. PubMed ID: 25159408
[TBL] [Abstract][Full Text] [Related]
15. Heuman indices of hydrophobicity of bile acids and their comparison with a newly developed and conventional molecular descriptors.
Poša M
Biochimie; 2014 Feb; 97():28-38. PubMed ID: 24076126
[TBL] [Abstract][Full Text] [Related]
16. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid.
Axelson M; Ellis E; Mörk B; Garmark K; Abrahamsson A; Björkhem I; Ericzon BG; Einarsson C
Hepatology; 2000 Jun; 31(6):1305-12. PubMed ID: 10827156
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands.
Festa C; Renga B; D'Amore C; Sepe V; Finamore C; De Marino S; Carino A; Cipriani S; Monti MC; Zampella A; Fiorucci S
J Med Chem; 2014 Oct; 57(20):8477-95. PubMed ID: 25247751
[TBL] [Abstract][Full Text] [Related]
18. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Yasukawa K; Iida T; Fujimoto Y
J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of deoxycholic acid in man.
Matern S; Sjövall J; Pomare EW; Heaton KW; Low-Beer TS
Med Biol; 1975 Apr; 53(2):107-13. PubMed ID: 1152551
[TBL] [Abstract][Full Text] [Related]
20. Novel, major 2α- and 2β-hydroxy bile alcohols and bile acids in the bile of Arapaima gigas, a large South American river fish.
Sato née Okihara R; Saito T; Ogata H; Nakane N; Namegawa K; Sekiguchi S; Omura K; Kurabuchi S; Mitamura K; Ikegawa S; Raines J; Hagey LR; Hofmann AF; Iida T
Steroids; 2016 Mar; 107():112-20. PubMed ID: 26768415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
